Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis

被引:0
作者
Yun-Jian Sheng
Jun-Ying Liu
Shi-Wen Tong
Huai-Dong Hu
Da-Zhi Zhang
Peng Hu
Hong Ren
机构
[1] The Second Affiliated Hospital of Chongqing Medical University Institute for Viral Hepatitis,Department of Infectious Diseases Key Laboratory of Molecular Biology for Infectious Diseases Ministry of Education
来源
Virology Journal | / 8卷
关键词
Chronic Hepatitis B; Lamivudine; Adefovir; Entecavir; Resistance; Combination therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 348 条
[1]  
Cao GW(2009)Clinical relevance and public health significance of hepatitis B virus genomic variations World J Gastroenterol 15 5761-5769
[2]  
Ganem D(2004)Hepatitis B virus infection--natural history and clinical consequences N Engl J Med 350 1118-1129
[3]  
Prince AM(2006)Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 65-73
[4]  
Chen CJ(2006)Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 678-686
[5]  
Yang HI(2008)Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach Gastroenterology 134 405-415
[6]  
Su J(2011)Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis Virol J 8 72-271
[7]  
Jen CL(2009)Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis J Viral Hepat 16 265-696
[8]  
You SL(2003)Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 36 687-539
[9]  
Lu SN(2007)Chronic hepatitis B Hepatology 45 507-1751
[10]  
Huang GT(2006)Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 1743-758